SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-01-09 12:04
Tx date 2024-01-05
$ONC
Oncolytics Biotech Inc.
Andrews, Patricia
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$79,200
+45,000 vol
$1.76 each
45,000
Filed 2024-01-09 11:46
Tx date 2024-01-05
$ONC
Oncolytics Biotech Inc.
Andrews, Patricia
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$79,200
+45,000 vol
$1.76 each
Filed 2024-01-09 11:46
Tx date 2024-01-05
$ONC
Oncolytics Biotech Inc.
Andrews, Patricia
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$79,200
+45,000 vol
$1.76 each
45,000
Filed 2024-01-09 11:42
Tx date 2024-01-05
$ONC
Oncolytics Biotech Inc.
Andrews, Patricia
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2023-12-13 15:19
Tx date 2023-12-11
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-2,105 vol
Filed 2023-12-13 15:05
Tx date 2023-12-08
$ONC
Oncolytics Biotech Inc.
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+15,200 vol
21,100
Filed 2023-12-13 15:05
Tx date 2023-12-08
$ONC
Oncolytics Biotech Inc.
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$108,297
+56,700 vol
$1.91 each
208,400
Filed 2023-12-13 15:03
Tx date 2023-12-08
$ONC
Oncolytics Biotech Inc.
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+62,100 vol
86,000
Filed 2023-12-13 15:02
Tx date 2023-12-08
$ONC
Oncolytics Biotech Inc.
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$442,547
+231,700 vol
$1.91 each
745,600
Filed 2023-12-13 15:00
Tx date 2023-12-08
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+19,500 vol
25,400
Filed 2023-12-13 14:59
Tx date 2023-12-08
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$139,048
+72,800 vol
$1.91 each
602,183
Filed 2023-12-13 14:57
Tx date 2023-12-08
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+62,100 vol
90,300
Filed 2023-12-13 14:57
Tx date 2023-12-08
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$442,547
+231,700 vol
$1.91 each
1,098,962
Filed 2023-12-13 14:54
Tx date 2023-12-08
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+93,800 vol
174,500
Filed 2023-12-13 14:52
Tx date 2023-12-08
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$668,500
+350,000 vol
$1.91 each
1,855,631
Filed 2023-12-12 09:57
Tx date 2023-12-11
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-2,105 vol
Filed 2023-12-12 09:54
Tx date 2023-12-11
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-3,157 vol
112,500
Filed 2023-11-20 10:22
Tx date 2023-11-19
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-53,000 vol
867,262
Filed 2023-11-20 09:36
Tx date 2023-11-19
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-150,000 vol
1,505,631
Filed 2023-11-17 09:37
Tx date 2023-11-15
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-145,000
-100,000 vol
$1.45 each
484,857
Filed 2023-08-18 11:57
Tx date 2023-08-15
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+80,700 vol
80,700
Filed 2023-08-18 11:56
Tx date 2023-08-15
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+5,900 vol
5,900
Filed 2023-08-18 11:55
Tx date 2023-08-15
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$59,891
+21,700 vol
$2.76 each
584,857
Filed 2023-08-18 11:54
Tx date 2023-08-15
$ONC
Oncolytics Biotech Inc.
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+5,900 vol
5,900
Filed 2023-08-18 11:53
Tx date 2023-02-24
$ONC
Oncolytics Biotech Inc.
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2023-08-18 11:53
Tx date 2023-08-15
$ONC
Oncolytics Biotech Inc.
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$59,891
+21,700 vol
$2.76 each
151,700
Filed 2023-08-18 11:51
Tx date 2023-08-15
$ONC
Oncolytics Biotech Inc.
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+23,900 vol
23,900
Filed 2023-08-18 11:50
Tx date 2020-08-01
$ONC
Oncolytics Biotech Inc.
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2023-08-18 11:49
Tx date 2023-08-15
$ONC
Oncolytics Biotech Inc.
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$245,363
+88,900 vol
$2.76 each
513,900
Filed 2023-08-18 11:47
Tx date 2023-08-15
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+5,900 vol
5,900
Filed 2023-08-18 11:46
Tx date 2019-02-25
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2023-08-18 11:45
Tx date 2023-08-15
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$59,891
+21,700 vol
$2.76 each
529,383
Filed 2023-08-18 11:43
Tx date 2023-08-15
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+28,200 vol
28,200
Filed 2023-08-18 11:41
Tx date 2023-08-15
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$289,800
+105,000 vol
$2.76 each
920,262
Filed 2023-08-18 11:38
Tx date 2023-08-15
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$830,759
+301,000 vol
$2.76 each
1,655,631
Filed 2023-08-18 11:36
Tx date 2023-08-15
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$82,800
+30,000 vol
$2.76 each
95,263
Filed 2023-08-18 11:34
Tx date 2023-08-15
$ONC
Oncolytics Biotech Inc.
Rigby, Jonathan
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$82,800
+30,000 vol
$2.76 each
75,000
Filed 2023-08-18 11:32
Tx date 2023-08-15
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$103,499
+37,500 vol
$2.76 each
115,657
Filed 2023-08-18 11:28
Tx date 2023-08-15
$ONC
Oncolytics Biotech Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$82,800
+30,000 vol
$2.76 each
75,000
Filed 2023-08-18 11:26
Tx date 2023-08-15
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$82,800
+30,000 vol
$2.76 each
95,263
Filed 2023-08-18 11:24
Tx date 2023-08-15
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$82,800
+30,000 vol
$2.76 each
95,263
Filed 2023-05-10 11:09
Tx date 2023-05-09
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-5,263 vol
78,157
Filed 2023-02-24 12:45
Tx date 2023-02-24
$ONC
Oncolytics Biotech Inc.
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
130,000
Filed 2022-12-19 10:44
Tx date 2022-12-17
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-13,157 vol
1,354,631
Filed 2022-12-19 10:40
Tx date 2022-12-17
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-4,210 vol
815,262
Filed 2022-12-13 12:49
Tx date 2022-12-09
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$231,000
+100,000 vol
$2.31 each
1,367,788
Filed 2022-12-13 12:42
Tx date 2022-12-09
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$184,800
+80,000 vol
$2.31 each
819,472
Filed 2022-12-13 12:32
Tx date 2022-12-09
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$184,800
+80,000 vol
$2.31 each
563,157
Filed 2022-12-13 12:26
Tx date 2022-12-09
$ONC
Oncolytics Biotech Inc.
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$184,800
+80,000 vol
$2.31 each
425,000
Filed 2022-12-13 12:20
Tx date 2022-12-12
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-526 vol
507,683
Filed 2022-12-13 12:16
Tx date 2022-12-09
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$184,800
+80,000 vol
$2.31 each
508,209
Filed 2022-11-14 15:29
Tx date 2022-11-13
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-21,052 vol
739,472
Filed 2022-09-08 15:50
Tx date 2022-08-30
$ONC
Oncolytics Biotech Inc.
Rigby, Jonathan
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$82,800
+45,000 vol
$1.84 each
45,000
Filed 2022-09-08 15:46
Tx date 2022-08-30
$ONC
Oncolytics Biotech Inc.
Rigby, Jonathan
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-06-23 10:00
Tx date 2022-06-20
$ONC
Oncolytics Biotech Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$51,299
+45,000 vol
$1.14 each
45,000
Filed 2022-06-23 09:57
Tx date 2022-06-16
$ONC
Oncolytics Biotech Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-06-21 15:44
Tx date 2022-06-20
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$34,200
+30,000 vol
$1.14 each
65,263
Filed 2022-06-21 15:42
Tx date 2022-06-20
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$34,200
+30,000 vol
$1.14 each
65,263
Filed 2022-06-21 15:40
Tx date 2022-06-20
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$34,200
+30,000 vol
$1.14 each
65,263
Filed 2022-06-21 15:37
Tx date 2022-06-20
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$42,749
+37,500 vol
$1.14 each
83,420
Filed 2022-06-17 11:22
Tx date 2022-06-16
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,851
+4,200 vol
$1.16 each
4,200
Filed 2022-06-17 11:21
Tx date 2019-02-25
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-06-16 09:40
Tx date 2022-06-15
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,340
+6,000 vol
$0.89 each
45,028
Filed 2022-06-15 14:59
Tx date 2022-06-15
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,669
+7,900 vol
$0.84 each
96,333
Filed 2022-06-14 17:00
Tx date 2022-06-14
$ONC
Oncolytics Biotech Inc.
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$9,429
+11,000 vol
$0.86 each
11,000
Filed 2022-06-14 16:59
Tx date 2020-08-01
$ONC
Oncolytics Biotech Inc.
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-06-14 16:00
Tx date 2022-06-14
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,160
+6,000 vol
$0.86 each
39,028
Filed 2022-06-14 15:17
Tx date 2022-06-14
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$43,065
+50,000 vol
$0.86 each
314,863
Filed 2022-06-14 15:15
Tx date 2022-06-14
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,821
+5,774 vol
$0.83 each
88,433
Filed 2022-03-09 10:13
Tx date 2022-03-08
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-442,414.05
-59,705 vol
$7.41 each
760,524
Filed 2022-03-09 10:11
Tx date 2022-03-08
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-988,412.49
-133,389 vol
$7.41 each
1,267,788
Filed 2022-03-09 10:09
Tx date 2022-03-09
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-109,193.76
-14,736 vol
$7.41 each
483,157
Filed 2022-03-09 10:07
Tx date 2022-03-08
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-77,997.66
-10,526 vol
$7.41 each
428,209
Filed 2022-01-04 14:28
Tx date 2022-01-04
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+8,287 vol
264,863
Filed 2022-01-04 14:27
Tx date 2022-01-04
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-8,287 vol
0
Filed 2022-01-04 14:24
Tx date 2022-01-04
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,142 vol
121,925
Filed 2022-01-04 14:22
Tx date 2022-01-04
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-3,142 vol
0
Filed 2022-01-04 14:08
Tx date 2022-01-04
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+6,837 vol
189,941
Filed 2022-01-04 14:07
Tx date 2022-01-04
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-6,837 vol
0
Filed 2021-12-15 09:50
Tx date 2021-12-14
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-842 vol
438,735
Filed 2021-12-15 09:48
Tx date 2021-12-14
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-3,684 vol
820,229
Filed 2021-12-15 09:46
Tx date 2021-12-14
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-13,157 vol
1,401,177
Filed 2021-12-13 17:42
Tx date 2021-12-10
$ONC
Oncolytics Biotech Inc.
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$114,400
+55,000 vol
$2.08 each
345,000
Filed 2021-12-13 17:40
Tx date 2021-12-10
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$114,400
+55,000 vol
$2.08 each
439,577
Filed 2021-12-13 17:35
Tx date 2021-12-10
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$114,400
+55,000 vol
$2.08 each
497,893
Filed 2021-12-13 17:34
Tx date 2021-12-10
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$114,400
+55,000 vol
$2.08 each
823,913
Filed 2021-12-13 17:32
Tx date 2021-12-10
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$135,200
+65,000 vol
$2.08 each
1,414,334
Filed 2021-10-04 18:36
Tx date 2021-10-01
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,496 vol
48,948
Filed 2021-10-04 18:34
Tx date 2021-10-01
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
54 - Exercise of warrants

-8,134 vol
0
Filed 2021-10-04 18:27
Tx date 2021-10-01
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+8,134 vol
256,576
Filed 2021-10-04 18:26
Tx date 2021-10-01
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-8,134 vol
8,287
Filed 2021-10-04 18:26
Tx date 2021-09-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+6,101 vol
248,442
Filed 2021-10-04 18:24
Tx date 2021-09-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-6,101 vol
16,421
Filed 2021-10-04 18:18
Tx date 2021-10-01
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+8,134 vol
183,104
Filed 2021-10-04 18:17
Tx date 2021-10-01
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-8,134 vol
6,837
Filed 2021-10-04 18:16
Tx date 2021-09-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+5,033 vol
174,970
Filed 2021-10-04 18:15
Tx date 2021-09-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-5,033 vol
14,971
Filed 2021-10-04 18:09
Tx date 2021-10-01
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+8,134 vol
118,783
Filed 2021-10-04 18:08
Tx date 2021-10-01
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-8,134 vol
3,142
Filed 2021-10-04 18:07
Tx date 2021-09-30
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+2,313 vol
110,649
Filed 2021-10-04 18:04
Tx date 2021-09-30
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-2,313 vol
11,276
Filed 2021-07-28 10:36
Tx date 2021-07-27
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-77,559.30
-1,894 vol
$40.95 each
1,349,334
Filed 2021-06-30 16:17
Tx date 2021-06-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+5,033 vol
169,937
Filed 2021-06-30 16:15
Tx date 2021-06-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-5,033 vol
20,004
Filed 2021-06-30 16:09
Tx date 2021-06-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+6,101 vol
242,341
Filed 2021-06-30 16:06
Tx date 2021-06-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-6,101 vol
22,522
Filed 2021-06-30 16:00
Tx date 2021-06-30
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-2,313 vol
13,589
Filed 2021-06-30 11:25
Tx date 2021-06-30
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Holder: Paul Holtham (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$7,933
+2,313 vol
$3.43 each
5,313
Filed 2021-06-07 12:48
Tx date 2021-06-07
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$25,123
+7,000 vol
$3.59 each
108,336
Filed 2021-04-01 10:31
Tx date 2021-03-31
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+2,540 vol
164,904
Filed 2021-04-01 10:29
Tx date 2021-03-31
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-2,540 vol
25,037
Filed 2021-04-01 10:27
Tx date 2021-03-31
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,079 vol
236,240
Filed 2021-04-01 10:26
Tx date 2021-03-31
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-3,079 vol
28,623
Filed 2021-04-01 10:24
Tx date 2021-03-31
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,167 vol
101,336
Filed 2021-04-01 10:22
Tx date 2021-03-31
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-1,167 vol
15,902
Filed 2021-03-12 19:14
Tx date 2021-03-12
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+22,105 vol
33,028
Filed 2021-03-12 19:13
Tx date 2021-03-12
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Share Units
57 - Exercise of rights

-22,105 vol
0
Filed 2021-03-12 19:12
Tx date 2021-03-12
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+34,736 vol
82,659
Filed 2021-03-12 19:10
Tx date 2021-03-12
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Share Units
57 - Exercise of rights

-34,736 vol
0
Filed 2021-03-12 18:26
Tx date 2021-03-08
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$102,000
+30,000 vol
$3.40 each
35,263
Filed 2021-03-12 18:25
Tx date 2021-03-08
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$102,000
+30,000 vol
$3.40 each
35,263
Filed 2021-03-12 18:23
Tx date 2021-03-08
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$127,500
+37,500 vol
$3.40 each
45,920
Filed 2021-03-12 18:21
Tx date 2021-03-08
$ONC
Oncolytics Biotech Inc.
Kruimer, Leonard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$102,000
+30,000 vol
$3.40 each
80,000
Filed 2021-03-12 18:19
Tx date 2021-03-08
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$102,000
+30,000 vol
$3.40 each
35,263
Filed 2021-03-12 18:17
Tx date 2021-03-08
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$102,000
+30,000 vol
$3.40 each
35,263
Filed 2021-03-12 18:15
Tx date 2021-03-08
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$527,000
+155,000 vol
$3.40 each
768,913
Filed 2021-03-12 18:13
Tx date 2021-03-08
$ONC
Oncolytics Biotech Inc.
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$408,000
+120,000 vol
$3.40 each
290,000
Filed 2021-03-12 18:11
Tx date 2021-03-08
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$153,000
+45,000 vol
$3.40 each
384,577
Filed 2021-03-12 18:09
Tx date 2021-03-08
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$289,000
+85,000 vol
$3.40 each
442,893
Filed 2021-03-12 18:06
Tx date 2021-03-08
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,428,000
+420,000 vol
$3.40 each
1,351,228
Filed 2021-02-26 15:06
Tx date 2021-02-24
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-14,500
-10,000 vol
$1.45 each
339,577
Filed 2021-02-14 16:40
Tx date 2020-12-14
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-167,963.04
-2,631 vol
$63.84 each
613,913
Filed 2021-02-14 16:34
Tx date 2020-12-14
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-772,783.20
-12,105 vol
$63.84 each
931,228
Filed 2021-02-14 16:32
Tx date 2020-12-14
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-13,406.40
-210 vol
$63.84 each
349,577
Filed 2020-12-15 10:17
Tx date 2020-12-14
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-13,406.40
-210 vol
$63.84 each
Filed 2020-12-15 10:13
Tx date 2020-12-14
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-167,963.04
-2,631 vol
$63.84 each
Filed 2020-12-15 10:11
Tx date 2020-12-14
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-772,783.20
-12,105 vol
$63.84 each
Filed 2021-01-15 10:46
Tx date 2021-01-13
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+462 vol
45,452
Filed 2021-01-15 10:43
Tx date 2021-01-13
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-1,239 vol
8,134
Filed 2021-01-15 10:34
Tx date 2021-01-13
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,982 vol
233,161
Filed 2021-01-15 10:32
Tx date 2021-01-13
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-1,982 vol
31,702
Filed 2021-01-15 10:30
Tx date 2021-01-13
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,303 vol
162,364
Filed 2021-01-15 10:29
Tx date 2021-01-13
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-3,303 vol
27,577
Filed 2021-01-04 15:46
Tx date 2020-12-31
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+1,239 vol
9,373
Filed 2021-01-04 15:43
Tx date 2020-12-31
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,667 vol
231,179
Filed 2021-01-04 15:41
Tx date 2020-12-31
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+1,982 vol
33,684
Filed 2021-01-04 15:39
Tx date 2020-12-31
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-1,667 vol
31,702
Filed 2021-01-04 15:37
Tx date 2020-12-31
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,053 vol
100,169
Filed 2021-01-04 15:36
Tx date 2020-12-31
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-1,053 vol
17,069
Filed 2021-01-04 15:32
Tx date 2020-12-31
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+926 vol
159,061
Filed 2021-01-04 15:21
Tx date 2020-12-31
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+3,303 vol
30,880
Filed 2021-01-04 15:20
Tx date 2020-12-31
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-926 vol
27,577
Filed 2020-12-16 17:04
Tx date 2020-12-11
$ONC
Oncolytics Biotech Inc.
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$317,000
+100,000 vol
$3.17 each
170,000
Filed 2020-12-16 17:01
Tx date 2020-12-11
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$634,000
+200,000 vol
$3.17 each
357,893
Filed 2020-12-16 16:59
Tx date 2020-12-11
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$634,000
+200,000 vol
$3.17 each
349,787
Filed 2020-12-16 16:57
Tx date 2020-12-11
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$792,500
+250,000 vol
$3.17 each
616,544
Filed 2020-12-16 16:55
Tx date 2020-12-11
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$951,000
+300,000 vol
$3.17 each
943,333
Filed 2020-12-15 10:17
Tx date 2020-12-14
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-13,406.40
-210 vol
$63.84 each
149,577
Filed 2020-12-15 10:13
Tx date 2020-12-14
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-167,963.04
-2,631 vol
$63.84 each
363,913
Filed 2020-12-15 10:11
Tx date 2020-12-14
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-772,783.20
-12,105 vol
$63.84 each
631,228
Filed 2020-12-02 16:08
Tx date 2020-12-01
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,713 vol
44,990
Filed 2020-12-02 16:06
Tx date 2020-12-01
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-3,971 vol
8,134
Filed 2020-12-02 16:02
Tx date 2020-12-01
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,971 vol
229,512
Filed 2020-12-02 16:01
Tx date 2020-12-01
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-3,971 vol
33,369
Filed 2020-12-02 15:59
Tx date 2020-12-01
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,971 vol
63,761
Filed 2020-12-02 15:58
Tx date 2020-12-01
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-3,971 vol
8,134
Filed 2020-12-02 15:56
Tx date 2020-12-01
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,971 vol
158,135
Filed 2020-12-02 15:55
Tx date 2020-12-01
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-3,971 vol
28,503
Filed 2020-12-02 15:52
Tx date 2020-12-01
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,971 vol
99,116
Filed 2020-12-02 15:50
Tx date 2020-12-01
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-3,971 vol
18,122
Filed 2020-11-10 09:55
Tx date 2020-11-09
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-9,775.50
-210 vol
$46.55 each
149,787
Filed 2020-10-06 09:45
Tx date 2020-10-01
$ONC
Oncolytics Biotech Inc.
Kruimer, Leonard
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+17,483 vol
22,294
Filed 2020-10-05 19:51
Tx date 2020-10-05
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+8,428 vol
43,277
Filed 2020-10-05 19:50
Tx date 2020-10-05
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-19,666 vol
12,105
Filed 2020-10-05 19:50
Tx date 2020-10-01
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+17,483 vol
31,771
Filed 2020-10-05 19:45
Tx date 2020-10-05
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+11,010 vol
59,790
Filed 2020-10-05 19:44
Tx date 2020-10-05
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-17,483 vol
12,105
Filed 2020-10-05 19:43
Tx date 2020-10-01
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+17,483 vol
29,588
Filed 2020-10-05 19:30
Tx date 2020-10-05
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+23,305 vol
154,164
Filed 2020-10-05 19:26
Tx date 2020-10-05
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-23,305 vol
32,474
Filed 2020-10-05 19:26
Tx date 2020-10-01
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+17,483 vol
55,779
Filed 2020-10-05 19:22
Tx date 2020-10-05
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+17,483 vol
95,145
Filed 2020-10-05 19:21
Tx date 2020-10-05
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-17,483 vol
22,093
Filed 2020-10-05 19:20
Tx date 2020-10-01
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+17,483 vol
39,576
Filed 2020-10-05 19:16
Tx date 2020-10-05
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+20,976 vol
225,541
Filed 2020-10-05 19:15
Tx date 2020-10-05
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-20,976 vol
37,340
Filed 2020-10-05 19:13
Tx date 2020-10-01
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+17,483 vol
58,316
Filed 2020-10-02 10:33
Tx date 2020-09-30
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+2,183 vol
14,288
Filed 2020-10-02 10:29
Tx date 2020-09-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,811 vol
204,565
Filed 2020-10-02 10:28
Tx date 2020-09-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-1,811 vol
40,833
Filed 2020-10-02 10:26
Tx date 2020-09-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+3,493 vol
42,644
Filed 2020-10-02 10:21
Tx date 2020-09-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,006 vol
130,859
Filed 2020-10-02 10:18
Tx date 2020-09-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-1,006 vol
38,296
Filed 2020-10-02 10:09
Tx date 2020-09-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-6,828 vol
Filed 2020-10-02 10:08
Tx date 2020-09-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+5,822 vol
39,302
Filed 2020-10-02 10:03
Tx date 2020-09-30
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,144 vol
77,662
Filed 2020-10-02 10:02
Tx date 2020-09-30
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-1,144 vol
22,093
Filed 2020-08-28 10:04
Tx date 2020-08-28
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,105
+4,300 vol
$2.35 each
76,518
Filed 2020-08-05 12:12
Tx date 2020-08-01
$ONC
Oncolytics Biotech Inc.
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$198,800
+70,000 vol
$2.84 each
70,000
Filed 2020-08-05 12:08
Tx date 2020-08-01
$ONC
Oncolytics Biotech Inc.
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-07-07 10:46
Tx date 2020-07-06
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+2,896 vol
202,754
Filed 2020-07-07 10:45
Tx date 2020-07-06
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-2,896 vol
39,151
Filed 2020-07-07 10:43
Tx date 2020-07-06
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+4,827 vol
129,853
Filed 2020-07-07 10:42
Tx date 2020-07-06
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-4,827 vol
33,480
Filed 2020-07-07 10:40
Tx date 2020-07-06
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,810 vol
34,849
Filed 2020-07-07 10:38
Tx date 2020-07-06
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-1,810 vol
12,105
Filed 2020-07-07 10:35
Tx date 2020-07-03
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+4,210 vol
10,315
Filed 2020-07-07 10:34
Tx date 2020-07-03
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-4,210 vol
0
Filed 2020-07-03 10:14
Tx date 2020-06-30
$ONC
Oncolytics Biotech Inc.
Kruimer, Leonard
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+1,810 vol
4,811
Filed 2020-07-03 10:12
Tx date 2020-06-30
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+1,810 vol
13,915
Filed 2020-07-03 10:08
Tx date 2020-06-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+2,368 vol
199,858
Filed 2020-07-03 10:07
Tx date 2020-06-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+2,896 vol
42,047
Filed 2020-07-03 10:06
Tx date 2020-06-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-2,368 vol
39,151
Filed 2020-07-03 09:58
Tx date 2020-06-30
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,496 vol
72,218
Filed 2020-07-03 09:56
Tx date 2020-06-30
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-1,496 vol
23,237
Filed 2020-07-03 09:51
Tx date 2020-06-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,315 vol
125,026
Filed 2020-07-03 09:50
Tx date 2020-06-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+4,827 vol
38,307
Filed 2020-07-03 09:49
Tx date 2020-06-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-1,315 vol
33,480
Filed 2020-04-06 16:46
Tx date 2020-04-06
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+5,383 vol
197,490
Filed 2020-04-06 16:45
Tx date 2020-04-06
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-5,383 vol
41,519
Filed 2020-04-06 16:42
Tx date 2020-04-06
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+2,212 vol
33,039
Filed 2020-04-06 16:41
Tx date 2020-04-06
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-2,212 vol
12,105
Filed 2020-04-06 16:39
Tx date 2020-04-06
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,165 vol
70,722
Filed 2020-04-06 16:34
Tx date 2020-04-06
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-1,165 vol
24,733
Filed 2020-04-06 16:25
Tx date 2020-04-06
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+7,291 vol
123,711
Filed 2020-04-06 16:23
Tx date 2020-04-06
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-7,291 vol
34,795
Filed 2020-04-02 10:08
Tx date 2020-03-31
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+3,539 vol
46,902
Filed 2020-04-02 10:06
Tx date 2020-03-31
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+6,267 vol
42,086
Filed 2020-04-02 10:04
Tx date 2020-03-31
$ONC
Oncolytics Biotech Inc.
Kruimer, Leonard
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+2,212 vol
3,001
Filed 2020-04-02 10:02
Tx date 2020-03-31
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+2,212 vol
14,317
Filed 2020-03-30 10:35
Tx date 2020-03-27
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Holder: Paul Holtham (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$6,089
+3,000 vol
$2.03 each
3,000
Filed 2020-03-30 10:03
Tx date 2020-03-27
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Holder: Paul Holtham (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$6,000
+3,000 vol
$2.00 each
Filed 2020-03-30 10:02
Tx date 2014-06-18
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Holder: Paul Holtham (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-03-30 09:48
Tx date 2020-03-27
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,000
+3,000 vol
$2.00 each
69,557
Filed 2020-03-09 10:21
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$145,000
+100,000 vol
$1.45 each
157,893
Filed 2020-03-09 10:20
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$253,750
+175,000 vol
$1.45 each
643,333
Filed 2020-03-09 10:19
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$181,250
+125,000 vol
$1.45 each
366,544
Filed 2020-03-09 10:17
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$50,750
+35,000 vol
$1.45 each
87,893
Filed 2020-03-09 10:15
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
Laeufle, Rita
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$181,250
+125,000 vol
$1.45 each
175,000
Filed 2020-03-09 10:13
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$145,000
+100,000 vol
$1.45 each
159,997
Filed 2019-12-18 15:52
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$50,750
+35,000 vol
$1.45 each
Filed 2019-12-18 15:49
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$145,000
+100,000 vol
$1.45 each
Filed 2019-12-18 15:43
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
Laeufle, Rita
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$181,250
+125,000 vol
$1.45 each
Filed 2019-12-18 15:39
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$145,000
+100,000 vol
$1.45 each
Filed 2019-12-18 15:35
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$181,250
+125,000 vol
$1.45 each
Filed 2019-12-18 15:32
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$253,750
+175,000 vol
$1.45 each
Filed 2020-02-21 15:57
Tx date 2020-02-20
$ONC
Oncolytics Biotech Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+4,210 vol
9,315
Filed 2020-02-21 15:56
Tx date 2020-02-20
$ONC
Oncolytics Biotech Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Share Units
57 - Exercise of rights

-4,210 vol
0
Filed 2020-01-17 10:59
Tx date 2020-01-16
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,968 vol
66,557
Filed 2020-01-17 10:54
Tx date 2020-01-16
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+10,526 vol
192,107
Filed 2020-01-17 10:52
Tx date 2020-01-16
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-10,526 vol
43,363
Filed 2020-01-17 10:50
Tx date 2020-01-16
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+10,526 vol
48,780
Filed 2020-01-17 10:47
Tx date 2020-01-16
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-10,526 vol
12,105
Filed 2020-01-17 10:43
Tx date 2020-01-16
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+10,526 vol
Filed 2020-01-17 10:38
Tx date 2020-01-16
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-10,526 vol
25,898
Filed 2020-01-17 10:35
Tx date 2020-01-16
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+15,789 vol
116,420
Filed 2020-01-17 10:33
Tx date 2020-01-16
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-15,789 vol
35,819
Filed 2020-01-10 18:18
Tx date 2020-01-06
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-66,995.60
-14,000 vol
$4.79 each
30,827
Filed 2020-01-10 15:29
Tx date 2020-01-06
$ONC
Oncolytics Biotech Inc.
Kruimer, Leonard
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+789 vol
789
Filed 2020-01-10 15:28
Tx date 2019-10-02
$ONC
Oncolytics Biotech Inc.
Kruimer, Leonard
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2020-01-08 16:00
Tx date 2020-01-06
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,413 vol
181,581
Filed 2020-01-08 15:54
Tx date 2020-01-06
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-6,282 vol
51,608
Filed 2020-01-08 15:53
Tx date 2020-01-06
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+3,748 vol
57,890
Filed 2020-01-08 14:35
Tx date 2020-01-06
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-14,500
-10,000 vol
$1.45 each
149,997
Filed 2019-12-18 15:52
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$50,750
+35,000 vol
$1.45 each
87,893
Filed 2019-12-18 15:49
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$145,000
+100,000 vol
$1.45 each
159,997
Filed 2019-12-18 15:43
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
Laeufle, Rita
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$181,250
+125,000 vol
$1.45 each
175,000
Filed 2019-12-18 15:39
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$145,000
+100,000 vol
$1.45 each
157,893
Filed 2019-12-18 15:35
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$181,250
+125,000 vol
$1.45 each
366,544
Filed 2019-12-18 15:32
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$253,750
+175,000 vol
$1.45 each
643,333
Filed 2019-12-09 10:21
Tx date 2019-12-08
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-91,773.99
-3,157 vol
$29.07 each
468,333
Filed 2019-12-09 10:17
Tx date 2019-12-08
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-30,581.64
-1,052 vol
$29.07 each
241,544
Filed 2019-10-21 17:25
Tx date 2019-10-02
$ONC
Oncolytics Biotech Inc.
Kruimer, Leonard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$27,000
+50,000 vol
$0.54 each
50,000
Filed 2019-10-21 17:21
Tx date 2019-10-02
$ONC
Oncolytics Biotech Inc.
Kruimer, Leonard
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-10-08 09:49
Tx date 2019-10-03
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-8,377 vol
22,631
Filed 2019-10-08 09:45
Tx date 2019-10-03
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+5,182 vol
38,254
Filed 2019-10-08 09:44
Tx date 2019-10-08
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-8,377 vol
Filed 2019-10-04 11:32
Tx date 2019-10-03
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+8,377 vol
178,168
Filed 2019-10-04 11:31
Tx date 2019-10-01
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+44,827 vol
93,791
Filed 2019-10-04 11:31
Tx date 2019-09-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+10,136 vol
48,964
Filed 2019-10-04 11:23
Tx date 2019-09-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-10,136 vol
63,786
Filed 2019-10-04 11:17
Tx date 2019-10-03
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-8,377 vol
55,409
Filed 2019-10-04 11:13
Tx date 2019-10-01
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-44,827 vol
63,786
Filed 2019-10-04 11:10
Tx date 2019-10-01
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+44,827 vol
108,613
Filed 2019-10-04 11:10
Tx date 2019-09-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-10,139 vol
Filed 2019-10-04 11:09
Tx date 2019-09-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+8,963 vol
73,922
Filed 2019-10-04 11:03
Tx date 2019-10-03
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+8,377 vol
94,349
Filed 2019-10-04 11:02
Tx date 2019-10-01
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+44,827 vol
85,972
Filed 2019-10-04 11:01
Tx date 2019-09-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+19,695 vol
41,145
Filed 2019-10-04 11:00
Tx date 2019-10-03
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-8,377 vol
54,142
Filed 2019-10-04 10:59
Tx date 2019-10-01
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-44,827 vol
62,519
Filed 2019-10-04 10:58
Tx date 2019-10-01
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+44,827 vol
107,346
Filed 2019-10-04 10:56
Tx date 2019-09-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-19,695 vol
62,519
Filed 2019-10-04 10:55
Tx date 2019-09-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+17,739 vol
82,214
Filed 2019-10-04 10:43
Tx date 2019-10-01
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+27,809 vol
33,072
Filed 2019-10-04 10:39
Tx date 2019-10-01
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-44,827 vol
31,008
Filed 2019-10-04 10:38
Tx date 2019-10-01
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+44,827 vol
75,835
Filed 2019-10-04 10:35
Tx date 2019-10-03
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+8,377 vol
62,589
Filed 2019-10-04 10:34
Tx date 2019-10-01
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+44,827 vol
54,212
Filed 2019-10-04 10:32
Tx date 2019-10-03
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-8,377 vol
36,424
Filed 2019-10-04 10:31
Tx date 2019-10-01
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-44,827 vol
44,801
Filed 2019-10-04 10:30
Tx date 2019-10-01
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+44,827 vol
89,628
Filed 2019-10-04 10:24
Tx date 2019-10-01
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+44,827 vol
44,827
Filed 2019-10-04 10:23
Tx date 2017-11-02
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-10-04 10:22
Tx date 2019-10-01
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-44,827 vol
12,105
Filed 2019-10-04 10:21
Tx date 2019-10-01
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+44,827 vol
56,932
Filed 2019-10-03 15:51
Tx date 2019-10-03
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$22,230
+38,000 vol
$0.58 each
114,828
Filed 2019-10-02 15:54
Tx date 2019-10-02
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$22,040
+38,000 vol
$0.58 each
76,828
Filed 2019-10-02 15:08
Tx date 2019-10-02
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,270
+10,000 vol
$0.427 each
47,923
Filed 2019-08-16 10:55
Tx date 2019-08-16
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$15,125
+25,000 vol
$0.60 each
38,828
Filed 2019-07-03 13:53
Tx date 2019-07-03
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+2,105 vol
6,105
Filed 2019-07-03 13:51
Tx date 2019-07-03
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-2,105 vol
4,210
Filed 2019-07-02 13:11
Tx date 2019-06-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+4,217 vol
13,828
Filed 2019-07-02 13:10
Tx date 2019-06-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-4,217 vol
64,959
Filed 2019-07-02 13:08
Tx date 2019-06-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+3,406 vol
69,176
Filed 2019-07-02 13:04
Tx date 2019-06-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+8,094 vol
21,450
Filed 2019-07-02 13:03
Tx date 2019-06-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-8,094 vol
64,475
Filed 2019-07-02 13:02
Tx date 2019-06-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+6,742 vol
72,569
Filed 2019-06-18 16:36
Tx date 2019-06-18
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,951
+1,300 vol
$2.27 each
37,923
Filed 2019-06-18 15:35
Tx date 2019-06-18
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,370
+1,500 vol
$2.25 each
10,923
Filed 2019-04-02 14:31
Tx date 2019-03-31
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+965 vol
9,385
Filed 2019-04-02 10:51
Tx date 2019-03-31
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+2,575 vol
Filed 2019-04-02 10:51
Tx date 2019-03-31
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+2,575 vol
10,995
Filed 2019-04-02 10:50
Tx date 2019-03-31
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-2,575 vol
44,801
Filed 2019-04-02 10:49
Tx date 2019-03-31
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+2,575 vol
47,376
Filed 2019-04-02 10:47
Tx date 2019-03-31
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,733 vol
9,611
Filed 2019-04-02 10:45
Tx date 2019-03-31
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-3,733 vol
65,770
Filed 2019-04-02 10:45
Tx date 2019-03-31
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+3,170 vol
69,503
Filed 2019-04-02 10:39
Tx date 2019-03-31
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+4,621 vol
13,356
Filed 2019-04-02 10:37
Tx date 2019-03-31
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-4,621 vol
65,827
Filed 2019-04-02 10:36
Tx date 2019-03-31
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+3,368 vol
70,448
Filed 2019-02-28
Tx date 2018-11-28
$ONC
Oncolytics Biotech Inc.
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-5,263 vol
Filed 2019-02-28
Tx date 2018-11-28
$ONC
Oncolytics Biotech Inc.
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-5,263 vol
31,008
Filed 2019-02-25
Tx date 2019-02-25
$ONC
Oncolytics Biotech Inc.
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
59,997
Filed 2019-02-25
Tx date 2019-02-25
$ONC
Oncolytics Biotech Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Share Units
00 - Opening Balance-Initial SEDI Report
4,210
Filed 2019-02-25
Tx date 2019-02-25
$ONC
Oncolytics Biotech Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
5,105
Filed 2019-02-25
Tx date 2019-02-25
$ONC
Oncolytics Biotech Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-02-25
Tx date 2019-02-25
$ONC
Oncolytics Biotech Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
52,893
Filed 2019-01-28
Tx date 2018-12-21
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$21,775
+12,500 vol
$1.74 each
Filed 2019-01-28
Tx date 2018-12-21
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
99 - Correction of information
$2,158
+1,250 vol
$1.73 each
36,623
Filed 2019-01-02
Tx date 2018-12-31
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+8,287 vol
66,333
Filed 2019-01-02
Tx date 2018-12-31
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+6,837 vol
67,080
Filed 2019-01-02
Tx date 2018-12-31
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,367 vol
8,735
Filed 2019-01-02
Tx date 2018-12-31
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-1,367 vol
60,243
Filed 2019-01-02
Tx date 2018-12-31
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+3,142 vol
44,801
Filed 2019-01-02
Tx date 2018-12-31
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-615 vol
58,046
Filed 2019-01-02
Tx date 2018-12-31
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+615 vol
5,878
Filed 2018-12-22
Tx date 2018-12-21
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,007
+1,250 vol
$2.41 each
9,423
Filed 2018-12-22
Tx date 2018-12-21
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$21,775
+12,500 vol
$1.74 each
47,873
Filed 2018-12-18
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
37 - Stock split or consolidation

-53,685 vol
6,315
Filed 2018-12-18
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-237,107 vol
27,893
Filed 2018-12-18
Tx date 2018-12-14
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$81,900
+30,000 vol
$2.73 each
57,893
Filed 2018-12-18
Tx date 2018-12-14
$ONC
Oncolytics Biotech Inc.
Laeufle, Rita
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$40,950
+15,000 vol
$2.73 each
50,000
Filed 2018-12-12
Tx date 2018-12-11
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,389
+4,000 vol
$2.10 each
4,000
Filed 2018-12-12
Tx date 2018-12-11
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,145
+5,000 vol
$2.03 each
35,373
Filed 2018-12-12
Tx date 2018-12-11
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$11,275
+4,100 vol
$2.75 each
8,173
Filed 2018-12-12
Tx date 2017-07-03
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-30
Tx date 2018-11-28
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-5,263 vol
58,661
Filed 2018-11-30
Tx date 2018-11-27
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+20,336 vol
63,924
Filed 2018-11-30
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
37 - Stock split or consolidation

-370,562 vol
43,588
Filed 2018-11-30
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
37 - Stock split or consolidation

-239,178 vol
28,137
Filed 2018-11-30
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-44,737 vol
5,263
Filed 2018-11-30
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
37 - Stock split or consolidation

-413,770 vol
48,673
Filed 2018-11-30
Tx date 2018-11-27
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+8,134 vol
36,271
Filed 2018-11-30
Tx date 2018-11-28
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+5,263 vol
7,368
Filed 2018-11-30
Tx date 2018-11-28
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+5,263 vol
5,263
Filed 2018-11-30
Tx date 2018-11-27
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+18,200 vol
66,873
Filed 2018-11-30
Tx date 2018-11-28
$ONC
Oncolytics Biotech Inc.
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-5,263 vol
31,008
Filed 2018-11-30
Tx date 2018-11-28
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+5,263 vol
5,263
Filed 2018-11-30
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-136,449 vol
16,051
Filed 2018-11-30
Tx date 2018-11-27
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+8,134 vol
12,105
Filed 2018-11-30
Tx date 2018-11-28
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-5,263 vol
31,008
Filed 2018-11-30
Tx date 2018-11-28
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-5,263 vol
61,610
Filed 2018-11-30
Tx date 2018-11-27
$ONC
Oncolytics Biotech Inc.
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+8,134 vol
36,271
Filed 2018-11-30
Tx date 2018-11-28
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+5,263 vol
8,420
Filed 2018-11-30
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-44,737 vol
5,263
Filed 2018-11-30
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-20,579 vol
2,421
Filed 2018-11-30
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
37 - Stock split or consolidation

-33,758 vol
3,971
Filed 2018-11-30
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
37 - Stock split or consolidation

-239,178 vol
28,137
Filed 2018-11-30
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
37 - Stock split or consolidation

-290,427 vol
34,162
Filed 2018-11-30
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-71,580 vol
8,420
Filed 2018-11-30
Tx date 2018-11-28
$ONC
Oncolytics Biotech Inc.
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+2,267 vol
4,688
Filed 2018-11-30
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-26,843 vol
3,157
Filed 2018-11-30
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-17,895 vol
2,105
Filed 2018-11-30
Tx date 2018-11-27
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+12,760 vol
46,922
Filed 2018-11-30
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-44,737 vol
5,263
Filed 2018-11-30
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-44,737 vol
5,263
Filed 2018-11-30
Tx date 2018-11-29
$ONC
Oncolytics Biotech Inc.
Laeufle, Rita
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$80,750
+25,000 vol
$3.23 each
35,000
Filed 2018-11-30
Tx date 2018-11-28
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-5,263 vol
41,659
Filed 2018-11-30
Tx date 2015-06-08
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-30
Tx date 2015-06-08
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-30
Tx date 2018-11-29
$ONC
Oncolytics Biotech Inc.
Laeufle, Rita
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
10,000
Filed 2018-11-23
Tx date 2018-11-19
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$182,320
+53,000 vol
$3.44 each
242,596
Filed 2018-11-23
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Share Units
37 - Stock split or consolidation

-295,264 vol
34,736
Filed 2018-11-23
Tx date 2018-11-19
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$516,000
+150,000 vol
$3.44 each
471,490
Filed 2018-11-23
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-34,627 vol
4,073
Filed 2018-11-23
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Share Units
37 - Stock split or consolidation

-187,895 vol
22,105
Filed 2018-11-23
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-258,177 vol
30,373
Filed 2018-11-23
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-2,732,710 vol
321,490
Filed 2018-11-23
Tx date 2018-05-22
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-1,611,604 vol
189,596
Filed 2018-04-04
Tx date 2018-03-31
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+29,251 vol
414,150
Filed 2018-04-04
Tx date 2018-03-31
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+24,132 vol
462,443
Filed 2018-04-04
Tx date 2018-03-31
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+11,091 vol
324,589
Filed 2018-03-16
Tx date 2018-03-15
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$442,416
+567,200 vol
$0.78 each
1,801,200
Filed 2018-03-16
Tx date 2018-03-15
$ONC
Oncolytics Biotech Inc.
Gutierrez-Lopez, Andres Alfonso
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$234,000
+300,000 vol
$0.78 each
450,000
Filed 2018-03-16
Tx date 2018-03-15
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$109,200
+140,000 vol
$0.78 each
265,000
Filed 2018-03-16
Tx date 2018-03-15
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$988,416
+1,267,200 vol
$0.78 each
3,054,200
Filed 2018-01-02
Tx date 2017-12-31
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+15,842 vol
384,899
Filed 2018-01-02
Tx date 2017-12-31
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+8,801 vol
438,311
Filed 2018-01-02
Tx date 2017-12-31
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+10,011 vol
313,498
Filed 2017-12-13
Tx date 2017-12-12
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-19,980
-9,000 vol
$2.22 each
1,234,000
Filed 2017-12-13
Tx date 2017-12-12
$ONC
Oncolytics Biotech Inc.
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
$-38,850
-17,500 vol
$2.22 each
152,500
Filed 2017-12-13
Tx date 2017-12-12
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-73,999.26
-33,333 vol
$2.22 each
1,787,000
Filed 2017-12-04
Tx date 2017-12-01
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+37,729 vol
369,057
Filed 2017-12-04
Tx date 2017-12-01
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+37,729 vol
267,315
Filed 2017-12-04
Tx date 2017-12-01
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+37,729 vol
429,510
Filed 2017-12-04
Tx date 2017-12-01
$ONC
Oncolytics Biotech Inc.
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+37,729 vol
267,315
Filed 2017-12-04
Tx date 2017-12-01
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+37,729 vol
303,487
Filed 2017-12-04
Tx date 2017-12-01
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+37,729 vol
37,729
Filed 2017-12-04
Tx date 2017-11-02
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2017-11-09
Tx date 2017-11-07
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$28,499
+50,000 vol
$0.57 each
50,000
Filed 2017-11-09
Tx date 2017-11-02
$ONC
Oncolytics Biotech Inc.
Brown, Deborah
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-10-04
Tx date 2017-09-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+17,212 vol
331,328
Filed 2017-10-04
Tx date 2017-09-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+9,562 vol
391,781
Filed 2017-10-04
Tx date 2017-09-30
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+10,877 vol
265,758
Filed 2017-07-05
Tx date 2017-06-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+22,500 vol
314,116
Filed 2017-07-05
Tx date 2017-06-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+12,500 vol
382,219
Filed 2017-07-05
Tx date 2017-06-30
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+14,219 vol
254,881
Filed 2017-07-05
Tx date 2017-07-03
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+60,000 vol
60,000
Filed 2017-07-05
Tx date 2017-07-03
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2017-07-05
Tx date 2017-07-03
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$65,000
+125,000 vol
$0.52 each
125,000
Filed 2017-07-05
Tx date 2017-07-03
$ONC
Oncolytics Biotech Inc.
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-04-11
Tx date 2017-04-06
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+17,527 vol
291,616
Filed 2017-04-11
Tx date 2017-04-06
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+9,737 vol
369,719
Filed 2017-04-11
Tx date 2017-04-06
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+11,076 vol
240,662
Filed 2017-01-19
Tx date 2017-01-16
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+100,000 vol
274,089
Filed 2017-01-19
Tx date 2017-01-16
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+100,000 vol
229,586
Filed 2017-01-19
Tx date 2017-01-16
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+150,000 vol
359,982
Filed 2017-01-19
Tx date 2016-09-09
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+210,000 vol
Filed 2017-01-19
Tx date 2016-09-09
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Share Units
56 - Grant of rights

+210,000 vol
210,000
Filed 2017-01-19
Tx date 2012-11-09
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-19
Tx date 2017-01-18
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-10,575
-4,700 vol
$2.25 each
1,243,000
Filed 2017-01-19
Tx date 2017-01-16
$ONC
Oncolytics Biotech Inc.
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$84,000
+300,000 vol
$0.28 each
1,247,700
Filed 2017-01-19
Tx date 2017-01-16
$ONC
Oncolytics Biotech Inc.
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+100,000 vol
229,586
Filed 2017-01-19
Tx date 2017-01-18
$ONC
Oncolytics Biotech Inc.
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
$-22,500
-10,000 vol
$2.25 each
170,000
Filed 2017-01-19
Tx date 2017-01-16
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+100,000 vol
229,586
Filed 2017-01-19
Tx date 2016-09-09
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+330,000 vol
Filed 2017-01-19
Tx date 2016-09-09
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Share Units
56 - Grant of rights

+330,000 vol
330,000
Filed 2017-01-19
Tx date 2003-04-17
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-19
Tx date 2017-01-16
$ONC
Oncolytics Biotech Inc.
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$112,000
+400,000 vol
$0.28 each
1,820,333
Filed 2017-01-04
Tx date 2016-12-31
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+14,444 vol
174,089
Filed 2017-01-04
Tx date 2016-12-31
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+24,073 vol
209,982
Filed 2016-11-23
Tx date 2016-11-10
$ONC
Oncolytics Biotech Inc.
Gutierrez-Lopez, Andres Alfonso
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Share Units
56 - Grant of rights

+300,000 vol
300,000
Filed 2016-11-23
Tx date 2016-10-31
$ONC
Oncolytics Biotech Inc.
Gutierrez-Lopez, Andres Alfonso
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2016-11-23
Tx date 2016-11-10
$ONC
Oncolytics Biotech Inc.
Gutierrez-Lopez, Andres Alfonso
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$39,000
+150,000 vol
$0.26 each
150,000
Filed 2016-11-23
Tx date 2016-10-31
$ONC
Oncolytics Biotech Inc.
Gutierrez-Lopez, Andres Alfonso
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-10-06
Tx date 2016-10-03
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+79,586 vol
159,645
Filed 2016-10-06
Tx date 2016-10-03
$ONC
Oncolytics Biotech Inc.
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+79,586 vol
129,586
Filed 2016-10-06
Tx date 2016-10-03
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+79,586 vol
185,909
Filed 2016-10-06
Tx date 2016-10-03
$ONC
Oncolytics Biotech Inc.
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+79,586 vol
129,586
Filed 2016-10-06
Tx date 2016-10-03
$ONC
Oncolytics Biotech Inc.
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+79,586 vol
129,586
Filed 2016-10-05
Tx date 2016-09-30
$ONC
Oncolytics Biotech Inc.
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+11,152 vol
80,059
Filed 2016-10-05
Tx date 2016-09-30
$ONC
Oncolytics Biotech Inc.
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+18,587 vol
106,323
Filed 2016-09-13
Tx date 2016-09-09
$ONC
Oncolytics Biotech Inc.
Thompson, Bradley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+660,000 vol
660,000
Filed 2016-09-13
Tx date 2003-04-04
$ONC
Oncolytics Biotech Inc.
Thompson, Bradley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2016-09-13